213 related articles for article (PubMed ID: 30590261)
1. Identification and characterization of a novel nanobody against duck hepatitis A virus type 1.
Xue W; Zhao Q; Li P; Zhang R; Lan J; Wang J; Yang X; Xie Z; Jiang S
Virology; 2019 Feb; 528():101-109. PubMed ID: 30590261
[TBL] [Abstract][Full Text] [Related]
2. Identification of a conserved neutralizing linear B-cell epitope in the VP1 proteins of duck hepatitis A virus type 1 and 3.
Zhang R; Zhou G; Xin Y; Chen J; Lin S; Tian Y; Xie Z; Jiang S
Vet Microbiol; 2015 Nov; 180(3-4):196-204. PubMed ID: 26427545
[TBL] [Abstract][Full Text] [Related]
3. Identification of a conserved B-cell epitope on duck hepatitis A type 1 virus VP1 protein.
Wu X; Li X; Zhang Q; Wulin S; Bai X; Zhang T; Wang Y; Liu M; Zhang Y
PLoS One; 2015; 10(2):e0118041. PubMed ID: 25706372
[TBL] [Abstract][Full Text] [Related]
4. Mapping a Type-specific Epitope by Monoclonal Antibody against VP3 Protein of Duck Hepatitis A Type 1 Virus.
Wu X; Zhang T; Meng F; Guo D; Yin X; Wulin S; Li C; Zhang Q; Liu M; Zhang Y
Sci Rep; 2017 Sep; 7(1):10820. PubMed ID: 28883462
[TBL] [Abstract][Full Text] [Related]
5. Evidence of VP1 of duck hepatitis A type 1 virus as a target of neutralizing antibodies and involving receptor-binding activity.
Li X; Zhao R; Lin W; Li C; Zhang T; Meng F; Liu M; Zhang Y
Virus Res; 2017 Jan; 227():240-244. PubMed ID: 27816429
[TBL] [Abstract][Full Text] [Related]
6. Preparation of single-chain antibody against VP3 protein of duck hepatitis virus type 1 by phage display technology.
Wang Y; Cui P; Zhu S; Meng T; Hao F; Zhu G; Zuo W
J Virol Methods; 2018 Jul; 257():73-78. PubMed ID: 29727718
[TBL] [Abstract][Full Text] [Related]
7. Molecular Evolution and Genetic Analysis of the Major Capsid Protein VP1 of Duck Hepatitis A Viruses: Implications for Antigenic Stability.
Ma X; Sheng Z; Huang B; Qi L; Li Y; Yu K; Liu C; Qin Z; Wang D; Song M; Li F
PLoS One; 2015; 10(7):e0132982. PubMed ID: 26173145
[TBL] [Abstract][Full Text] [Related]
8. [Indirect ELISA for simultaneous detection of antibodies against duck hepatitis A type 1 and 3 viruses].
Zhang Y; Ma X; Huang B; Li Y; Yu K; Li J; Liu C; Han H; Cui Y
Wei Sheng Wu Xue Bao; 2015 Apr; 55(4):501-9. PubMed ID: 26211325
[TBL] [Abstract][Full Text] [Related]
9. Oral vaccine of recombinant Lactococcus lactis expressing the VP1 protein of duck hepatitis A virus type 3 induces mucosal and systemic immune responses.
Song S; Li P; Zhang R; Chen J; Lan J; Lin S; Guo G; Xie Z; Jiang S
Vaccine; 2019 Jul; 37(31):4364-4369. PubMed ID: 31227355
[TBL] [Abstract][Full Text] [Related]
10. Characterization of monoclonal antibodies against duck hepatitis type 1 virus VP1 protein.
Zhang T; Li X; Wu X; Shaozhou W; Bai X; Liu S; Liu M; Zhang Y
J Virol Methods; 2014 Nov; 208():166-70. PubMed ID: 25110119
[TBL] [Abstract][Full Text] [Related]
11. Evidence of possible vertical transmission of duck hepatitis A virus type 1 in ducks.
Zhang R; Yang Y; Lan J; Xie Z; Zhang X; Jiang S
Transbound Emerg Dis; 2021 Mar; 68(2):267-275. PubMed ID: 32598568
[TBL] [Abstract][Full Text] [Related]
12. Development and evaluation of an indirect ELISA based on recombinant nonstructural protein 3A to detect antibodies to duck hepatitis A virus type 1.
Zhou S; Zhang S; Wang M; Cheng A; Zhu D; Chen S; Liu M; Zhao X; Jia R; Yang Q; Wu Y; Zhang S; Liu Y; Yu Y; Zhang L; Chen X
J Virol Methods; 2019 Jun; 268():56-61. PubMed ID: 30905595
[TBL] [Abstract][Full Text] [Related]
13. First Report of Duck Hepatitis A Virus 3 from Duckling Flocks of Egypt.
Hassan TIR; Eid AAM; Ghanem IAI; Shahin AM; Adael SAA; Mohamed FF
Avian Dis; 2020 Sep; 64(3):269-276. PubMed ID: 33205161
[TBL] [Abstract][Full Text] [Related]
14. Pathogenicity of duck hepatitis A virus type 3 and innate immune responses of the ducklings to virulent DHAV-3.
Zhang X; Cao C; Qu Z; Zhang W; Liu Y; Qi H; Hao C; Zhang W; Gao M; Wang J; Ma B
Mol Immunol; 2018 Mar; 95():30-38. PubMed ID: 29407574
[TBL] [Abstract][Full Text] [Related]
15. Live attenuated duck hepatitis virus vaccine in breeder ducks: Protective efficacy and kinetics of maternally derived antibodies.
Roh JH; Kang M
Vet Microbiol; 2018 Jun; 219():107-112. PubMed ID: 29778181
[TBL] [Abstract][Full Text] [Related]
16. Molecular epidemiology of duck hepatitis a virus types 1 and 3 in China, 2010-2015.
Wen X; Zhu D; Cheng A; Wang M; Chen S; Jia R; Liu M; Sun K; Zhao X; Yang Q; Wu Y; Chen X
Transbound Emerg Dis; 2018 Feb; 65(1):10-15. PubMed ID: 29076646
[TBL] [Abstract][Full Text] [Related]
17. Comparative pathogenicity of different subtypes of duck hepatitis A virus in Pekin ducklings.
Liu R; Shi S; Huang Y; Chen Z; Chen C; Cheng L; Fu G; Chen H; Wan C; Fu Q
Vet Microbiol; 2019 Jan; 228():181-187. PubMed ID: 30593365
[TBL] [Abstract][Full Text] [Related]
18. Detection, differentiation, and VP1 sequencing of duck hepatitis A virus type 1 and type 3 by a 1-step duplex reverse-transcription PCR assay.
Wen XJ; Cheng AC; Wang MS; Jia RY; Zhu DK; Chen S; Liu MF; Liu F; Chen XY
Poult Sci; 2014 Sep; 93(9):2184-92. PubMed ID: 25012848
[TBL] [Abstract][Full Text] [Related]
19. A Novel Peptide Isolated from a Phage Display Peptide Library Modeling Antigenic Epitope of DHAV-1 and DHAV-3.
Zhang R; Yang Y; Lan J; Lin S; Xie Z; Zhang X; Jiang S
Vaccines (Basel); 2020 Mar; 8(1):. PubMed ID: 32150877
[TBL] [Abstract][Full Text] [Related]
20. Protective efficacy of a bivalent live attenuated vaccine against duck hepatitis A virus types 1 and 3 in ducklings.
Kang M; Roh JH; Jang HK
Vet Microbiol; 2018 Feb; 214():108-112. PubMed ID: 29408021
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
